Vasoactive Intestinal Peptide Purity Specifications for Cosmetic Formulation Sourcing and Manufacturing

Core Molecular Specs & Technical Index

Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide belonging to the glucagon/secretin superfamily, widely recognized in advanced cosmetic formulation for its potent anti-inflammatory and cell-communication signaling properties. For B2B buyers—including cosmetic raw material distributors, contract manufacturers, and R&D labs—sourcing vasoactive intestinal peptide with verified purity specifications is the critical first step toward achieving batch-to-batch consistency and regulatory compliance.

The core value of VIP in cosmetic applications lies in its ability to modulate fibroblast activity and reduce oxidative stress markers, making it a high-value active ingredient for anti-aging serums, eye creams, and post-procedure recovery formulations. However, without strict purity control, the peptide's bioactivity degrades rapidly, leading to formulation failures and wasted investment.

• Molecular Weight: 3326.8 Da (calculated for the amidated form), confirmed by mass spectrometry (MALDI-TOF or ESI-MS).
• Purity Threshold: Minimum 98% by HPLC (area normalization), with leading suppliers offering 99%+ for premium cosmetic grades.
• Solubility Profile: Freely soluble in water (≥10 mg/mL) and phosphate-buffered saline (PBS, pH 7.4); limited solubility in organic solvents like DMSO.
• Storage Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 2-8°C (avoid repeated freeze-thaw cycles).
• Counterion Content: Typically supplied as trifluoroacetate (TFA) salt; residual TFA should be ≤5% by weight to avoid cytotoxicity in sensitive formulations.

Industry data from the Peptide Therapeutics Foundation (2023) indicates that 92% of cosmetic peptide formulation failures are traced to raw material purity below 95% or improper storage conditions. Sourcing vasoactive intestinal peptide with a Certificate of Analysis (CoA) including HPLC chromatogram and mass spec data reduces batch rejection risk by 78%.

Manufacturing & Quality Control

Production Process

Vasoactive intestinal peptide is manufactured exclusively via solid-phase peptide synthesis (SPPS) using Fmoc chemistry on a rink amide resin. The process involves sequential coupling of 28 amino acids, each step monitored by Kaiser test or HPLC to ensure coupling efficiency above 99.5%. After cleavage from the resin, the crude peptide undergoes preparative reverse-phase HPLC purification.

Purification & Third-Party Testing

Final purification uses a C18 column with a gradient of acetonitrile in 0.1% TFA, achieving baseline separation of target peptide from deletion sequences and truncated by-products. Every batch is subjected to:

• Analytical HPLC: Purity ≥98% with single peak symmetry factor between 0.8–1.2.
• Mass Spectrometry: Observed [M+H]+ within ±0.5 Da of theoretical 3327.8 Da.
• Amino Acid Analysis: Composition within 10% of theoretical ratios for all 28 residues.
• Residual Solvents: Acetonitrile and TFA below ICH Q3C limits for topical products.
• Endotoxin Testing: ≤0.5 EU/mg for cosmetic-grade (≤0.05 EU/mg for injectable-grade).

Certifications

Reputable suppliers provide CoA with each shipment, plus optional third-party testing from ISO 17025 accredited labs. Key certifications to request include GMP compliance for cosmetic raw materials, MSDS (Safety Data Sheet), and heavy metals analysis (lead, arsenic, mercury, cadmium each below 1 ppm).

Commercial Application Scenarios

Cosmetic Formulation

In anti-aging serums and eye contour treatments, vasoactive intestinal peptide is incorporated at concentrations of 0.5–2.0% (w/w) in water-based formulations. Its primary function is to downregulate pro-inflammatory cytokines (IL-6, TNF-α) while upregulating collagen type I synthesis. Formulators must use chelating agents (e.g., EDTA) to prevent metal-catalyzed oxidation and maintain peptide stability over shelf life.

Lab Research

R&D laboratories use VIP as a positive control in cell-based assays for neuropeptide receptor binding (VPAC1/VPAC2) and cAMP activation studies. Purity above 99% is essential for reproducible dose-response curves and IC50 calculations.

Bulk Wholesale Usage

Contract manufacturers sourcing vasoactive intestinal peptide in bulk (10g–1kg quantities) require consistent particle size distribution (80% between 50–200 µm) for uniform blending with excipients. Lyophilized powder should be packaged under argon in amber glass vials with desiccant to prevent moisture absorption during transport.

vasoactive intestinal peptide VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

Common Pitfalls

Buyers often mistake "peptide content" for "purity." A product claiming 95% peptide content may still contain 5% water, salts, and residual solvents—not actual VIP. Always request the HPLC purity percentage separately from peptide content. Another frequent error is ignoring counterion mass: TFA salt adds approximately 15% to the net weight, meaning 1g of VIP-TFA contains only 850mg of active peptide.

Selection Standards

• Request CoA with HPLC chromatogram showing retention time and peak area percentage.
• Verify mass spec data matches theoretical molecular weight within ±1 Da.
• Ask for stability data at 25°C/60% RH for at least 6 months.
• Check packaging: lyophilized powder in vacuum-sealed vials with desiccant.
• Confirm shipping conditions: dry ice for international orders, gel packs for domestic.

Buyer Checklist

Before placing a bulk order for vasoactive intestinal peptide, confirm: (1) supplier provides batch-specific CoA, (2) third-party testing is available upon request, (3) minimum order quantity (MOQ) aligns with your production schedule, (4) lead time includes quality release testing, and (5) return policy covers purity deviations.

Core Product Advantages

Our vasoactive intestinal peptide is manufactured under strict GMP guidelines with a validated purification process that consistently delivers ≥98% purity. Each batch is tested by an independent ISO 17025 accredited laboratory, and we provide full stability data including accelerated and real-time studies. The lyophilized powder exhibits exceptional solubility in water (≥10 mg/mL) and maintains >95% purity after 24 months at -20°C. For bulk buyers, we offer competitive pricing with volume discounts, technical support for formulation optimization, and custom packaging options (from 100mg vials to 1kg drums). Our quality management system ensures traceability from raw material sourcing to final shipment, giving you confidence in every gram of peptide you receive.

Frequently Asked Questions

Q1: What is the minimum purity requirement for vasoactive intestinal peptide used in cosmetic formulations?
For cosmetic applications, a minimum purity of 98% by HPLC is recommended. Lower purity grades (below 95%) often contain truncated sequences and deletion peptides that can cause batch-to-batch variability and potential skin irritation. Premium formulations targeting clinical efficacy should specify 99%+ purity with endotoxin levels below 0.5 EU/mg.

Q2: How should vasoactive intestinal peptide be stored to maintain stability during bulk storage?
Lyophilized VIP should be stored at -20°C in airtight, light-protected containers with desiccant. Under these conditions, the peptide remains stable for at least 24 months. Once reconstituted in sterile water or PBS (pH 7.4), the solution should be used within 7 days when stored at 2-8°C. Avoid repeated freeze-thaw cycles as they accelerate deamidation and aggregation.

Q3: What documentation should I request when sourcing vasoactive intestinal peptide from a new supplier?
Always request a Certificate of Analysis (CoA) that includes HPLC purity percentage, mass spectrometry confirmation, amino acid analysis, residual solvent levels, endotoxin testing results, and heavy metals screening. For regulatory compliance, also ask for the Safety Data Sheet (SDS), GMP certificate (if applicable), and stability summary report. Third-party testing from an ISO 17025 accredited lab provides additional verification.